ReThink Pharmaceuticals

Finding New Applications for Existing Drugs

Health Tech & Life Sciences
Non Active, Oct 2018
Pre-Seed Tel Aviv-Yafo, Israel Founded 2014
Last updated 2026-06-18
Total raised
$5K
Last: 2015-06
Stage
Pre-Seed
Founded
2014
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

ReThink Pharmaceuticals is a computational biotech company focused on drug repurposing. The company has developed a distinct algorithm based on evolutionary genomics (phylogenetic profiling) and innovative bioinformatics for drug repurposing. ReThink discovers new indications for drugs on the market and under clinical development, as well as for shelved drugs that failed for efficacy reasons in clinical trials. The companys approach aims to expand the spectrum of connections between drugs and diseases, enabling the generation of novel and highly accurate findings. ReThink seeks to work in partnership and collaboration with the pharmaceutical industry, medical institutions, and rare disease foundations to create value by enhancing the potential clinical and commercial success of repurposing options for existing assets.

Funding history · 1 round · $5K total

2015-06

Q&A

What is the current status of ReThink Pharmaceuticals?
ReThink Pharmaceuticals is currently inactive, with its status changed in October 2018.
What is ReThink Pharmaceuticals' primary focus?
ReThink Pharmaceuticals is a computational biotech company focused on drug repurposing, specifically finding new applications for existing drugs.
When was ReThink Pharmaceuticals founded?
ReThink Pharmaceuticals was founded in December 2014.
How many employees does ReThink Pharmaceuticals have?
ReThink Pharmaceuticals has 1-10 employees.
What was the total amount raised by ReThink Pharmaceuticals?
ReThink Pharmaceuticals raised a total of $5,000 USD.
When was ReThink Pharmaceuticals' last funding round and who was an investor?
ReThink Pharmaceuticals' last funding round occurred in June 2015, with Accelerator as an investor.
What is ReThink Pharmaceuticals' current funding stage?
ReThink Pharmaceuticals is in the Pre-Seed funding stage.
What is the primary sector of ReThink Pharmaceuticals?
ReThink Pharmaceuticals operates in the Health Tech & Life Sciences sector.

Team · 4

Founder · Co-Founder & CEO
LinkedIn ↗
Founder · Co-Founder & Business Development
LinkedIn ↗
Founder · Co-Founder & COO
LinkedIn ↗
Founder · Co-Founder & Scientific Adviser
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

bioinformaticsgenomicsdrug-discoverybig-data-analyticspharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)